US Patent Issued to BIOVERATIV THERAPEUTICS, FONDAZIONE TELETHON, OSPEDALE SAN RAFFAELE on Sept. 2 for "Lentiviral vector formulations" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,403,164, issued on Sept. 2, was assigned to BIOVERATIV THERAPEUTICS INC. (Waltham, Mass.), FONDAZIONE TELETHON (Rome) and OSPEDALE SAN RAFFAELE S.R.L. (Milan).

"Lentiviral vector formulations" was invented by Andrew Kroetsch (Waltham, Mass.) and Isidro Zarraga (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Lentiviral vector (LV) formulations, and pharmaceutical compositions comprising such LV formulations, with improved stability and suitable for systemic administration are provided. Methods for treating disorders, especially blood disorders, using systemic administration of LV formulations are also provided."

The patent was filed on Se...